Advanced search
Publication Cover
Bioengineered Volume 11, 2020 - Issue 1
Submit an article Journal homepage
1,136
Views
22
CrossRef citations to date
0
Altmetric
Research Paper

Long intergenic noncoding RNA01134 accelerates hepatocellular carcinoma progression by sponging microRNA-4784 and downregulating structure specific recognition protein 1

Shiyang Zhenga Department of thyroid and breast surgery, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China;b Department of breast surgery, The Third Affiliated Hospital of Guangzhou medical college, Guangzhou, ChinaView further author information
,
Yan Guoc Department of Obstetrics, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, ChinaCorrespondence[email protected]
View further author information
,
Lizhen Daic Department of Obstetrics, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, ChinaCorrespondence[email protected]
View further author information
,
Ziming Liangd Department of Hepatic Surgery and Liver Transplantation Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, ChinaView further author information
,
Qing Yangd Department of Hepatic Surgery and Liver Transplantation Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-4135-8688View further author information
ORCID Icon &
Shuhong Yid Department of Hepatic Surgery and Liver Transplantation Center, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, ChinaView further author information
Pages 1016-1026 | Received 06 Jul 2020, Accepted 31 Aug 2020, Published online: 24 Sep 2020

Reference

  • Schlachterman A, Craft WW, Hilgenfeldt E, et al.. Current and future treatments for hepatocellular carcinoma. World J Gastroenterol. 2015;21:8478–8491.
  • Sullivan KM, Kenerson HL, Pillarisetty VG, et al.. Precision oncology in liver cancer. Ann Transl Med. 2018;6:285.
  • Yin Z, Dong C, Jiang K, et al.. Heterogeneity of cancer-associated fibroblasts and roles in the progression, prognosis, and therapy of hepatocellular carcinoma. J Hematol Oncol. 2019;12:101.
  • Schmitt AM, Chang HY. Long Noncoding RNAs in Cancer Pathways. Cancer Cell. 2016;29:452–463.
  • Sarropoulos I, Marin R, Cardoso-Moreira M, et al.. Developmental dynamics of lncRNAs across mammalian organs and species. Nature. 2019;571:510–514.
  • Lin YH, Wu MH, Huang YH, et al.. Taurine up-regulated gene 1 functions as a master regulator to coordinate glycolysis and metastasis in hepatocellular carcinoma. Hepatology. 2018;67:188–203.
  • Wang YL, Liu JY, Yang JE, et al.. Lnc-UCID Promotes G1/S Transition and Hepatoma Growth by Preventing DHX9-Mediated CDK6 Down-regulation. Hepatology. 2019;70:259–275.
  • Xie C, Zhang LZ, Chen ZL, et al.. A hMTR4-PDIA3P1-miR-125/124-TRAF6 Regulatory Axis and Its Function in NF kappa B Signaling and Chemoresistance. Hepatology. 2020;71:1660–1677.
  • Lv H, Lv G, Han Q, et al.. Noncoding RNAs in liver cancer stem cells: The big impact of little things. Cancer Lett. 2018;418:51–63.
  • Wang Y, Zhu P, Luo J, et al.. LncRNA HAND2-AS1 promotes liver cancer stem cell self-renewal via BMP signaling. EMBO J. 2019;38:e101110.
  • Wang X, Sun W, Shen W, et al.. Long non-coding RNA DILC regulates liver cancer stem cells via IL-6/STAT3 axis. J Hepatol. 2016;64:1283–1294.
  • Wang Y, He L, Du Y, et al.. The long noncoding RNA lncTCF7 promotes self-renewal of human liver cancer stem cells through activation of Wnt signaling. Cell Stem Cell. 2015;16:413–425.
  • Xiao J-N, Yan T-H, Yu R-M, et al.. Long non-coding RNA UCA1 regulates the expression of Snail2 by miR-203 to promote hepatocellular carcinoma progression. J Cancer Res Clin Oncol. 2017;143:981–990.
  • Xin X, Wu M, Meng Q, et al.. Long noncoding RNA HULC accelerates liver cancer by inhibiting PTEN via autophagy cooperation to miR15a. Mol Cancer. 2018;17:94.
  • Wang Y, Sun L, Wang L, et al.. Long non-coding RNA DSCR8 acts as a molecular sponge for miR-485-5p to activate Wnt/β-catenin signal pathway in hepatocellular carcinoma. Cell Death Dis. 2018;9:851.
  • Wu W, He K, Guo Q, et al.. SSRP1 promotes colorectal cancer progression and is negatively regulated by miR-28-5p. J Cell Mol Med. 2019;23:3118–3129.
  • Ding Q, He K, Luo T, et al.. SSRP1 Contributes to the Malignancy of Hepatocellular Carcinoma and Is Negatively Regulated by miR-497. Mol Ther. 2016;24:903–914.
  • Ai J, Li W, Zeng R, et al.. Blockage of SSRP1/Ets-1/Pim-3 signalling enhances chemosensitivity of nasopharyngeal carcinoma to docetaxel in vitro. Biomed Pharmacother. 2016;83:1022–1031.
  • Tao Z, Wang L, Shen G, et al. Differential microRNA expression in aristolochic acid-induced upper urothelial tract cancers ex vivo. Mol med rep 2015;12:6533.
  • Feng Y, Qu L, Wang X, et al.. LINC01133 promotes the progression of cervical cancer by sponging miR-4784 to up-regulate AHDC1. Cancer Biol Ther. 2019;20:1453–1461.
  • Zhen Y, Xinghui Z, Chao W, et al.. Several microRNAs could predict survival in patients with hepatitis B-related liver cancer. 7:45195.
  • Friedman RC, Farh KK-H, Burge CB, et al.. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009;19.
  • Sun P, Zhang K, Hassan SH, et al.. Endothelium-Targeted Deletion of microRNA-15a/16-1 Promotes Post-Stroke Angiogenesis and Improves Long-Term Neurological Recovery. Circ Res. 2020;126(8):1040–1057.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.